Drug intelligence / Profile preview

sodium phosphate dibasic anhydrous + sodium phosphate monobasic

Development stage
Unknown
Lead developer
Salix Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Sodium phosphate dibasic anhydrous + sodium phosphate monobasic is an **oral small-molecule osmotic laxative combination** used primarily for **cleansing of the colon before colonoscopy in adults**. The product is marketed under brand names including **OsmoPrep** and **Visicol**. Its laxative effect is mediated by the **osmotic activity of phosphate salts in the intestinal lumen**, which draws water into the bowel, promotes catharsis, and facilitates bowel evacuation rather than acting through a discrete receptor or enzyme target. This combination has been developed and marketed for bowel preparation, while related sodium phosphate formulations administered by injection are used separately as phosphorus replacement products for hypophosphatemia and should not be conflated with the oral tablet bowel-prep product.

Brand names
OsmoPrepVisicol
Other names
monobasic sodium phosphate and dibasic sodium phosphate tabletssodium phosphate monobasic + sodium phosphate dibasic anhydroussodium phosphates tablets
02

Targets

Intestinal luminal osmolarity

Beyond the preview

Go deeper on sodium phosphate dibasic anhydrous + sodium phosphate monobasic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium phosphate dibasic anhydrous + sodium phosphate monobasic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call